Optimal dosing of 1st line antituberculosis and antiretroviral drugs in children- a pharmacokinetic study


This study will evaluate the 2010 WHO dosing recommendations for first line antituberculosis drugs in HIV-infected and uninfected children in South Africa and Malawi.

Funding source:

US National Institute of Health

Total ammount of funding:

+/- € 1.9 million

Funding period:

2011 - 2016

Role of EfGHI:

Prof Annelies Van Rie is a co-investigator


University of Cape Town (Helen McIlleron, PI)